Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The CRISPR Technology Market Today And What Is Its Future Size?
There has been remarkable growth in the market size of CRISPR technology in the past few years. The market is anticipated to inflate from $2.05 billion in 2024 to a whopping $2.53 billion in 2025, showcasing a compound annual growth rate (CAGR) of 23.4%. This substantial growth during the historic period can be accredited to a surge in funding and escalated R&D spending in the pharmaceutical domain.
The market size for crispr technology is projected to witness significant expansion in the coming years, escalating to a whopping $5.71 billion in 2029 with a compound annual growth rate (CAGR) of 22.6%. The advancements in the sphere of genome editing, a rising appetite for gene therapeutics, the spiraling demand in the pharmaceutical industry for new drug discoveries, an increase in the use of CRISPR in diagnostic procedures, growing requisites for CRISPR technologies in agricultural applications, and an overall increased acceptance of CRISPR technologies contribute to its growth in the projected period. Upcoming trends include cultivating novel next-generation technologies, refining CRISPR technologies for superior outcomes in fresh drug research and development, deploying artificial intelligence to enhance the proficiency and preciseness of gene editing using CRISPR, funding new methodologies like IDMseq to boost accuracy, and fostering partnerships with corporations.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4018&type=smp
Which Key Factors Are Fueling Growth In The CRISPR Technology Market?
The prospect of utilizing CRISPR technology for diagnostic purposes is forecasted to propel the market in this period. The Sherlock CRISPR SARS-CoV-2 kit, the initial diagnostic kit to employ CRISPR technology against infectious diseases like COVID-19, was granted emergency use authorization by the FDA in February 2021. Sherlock BioSciences Inc’s kit is a CRISPR-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) diagnostic test. The test specifically identifies RNA or DNA sequences of the SARS-CoV-2 virus in various samples, such as nasal swabs from the upper respiratory tract and lung fluids from bronchoalveolar lavage specimens. The diagnostic kit is extremely accurate and reliable, negating the possibility of false negatives or positives. The broader application of the CRISPR technology for diagnosing infectious diseases is anticipated to drive the demand for products and services based on CRISPR technology.
How Is The CRISPR Technology Market Segmented Across Key Categories?
The crispr technologymarket covered in this report is segmented –
1) By Product Type: Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products
2) By Application: Biomedical, Agriculture, Diagnostics, Other Applications
3) By End-User: Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs)
Subsegments:
1) By Design Tools: CRISPR Design Software; sgRNA Design Tools; Bioinformatics Platforms
2) By Plasmid and Vector: Plasmid Vectors; Viral Vectors; Bacterial Vectors
3) By Cas9 and gRNA: Cas9 Proteins; Guide RNA (gRNA) Products; Cas9 Complexes
4) By Delivery System Products: Electroporation Systems; Lipid-Based Delivery Systems; Viral Delivery Systems; Nanoparticle-Based Delivery Systems
What Current And Upcoming Trends Are Shaping The CRISPR Technology Market?
Leading businesses in the CRISPR technology market are forming strategic alliances with the aim of delivering treatments for illnesses such as sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). Such collaborations enable companies to utilize each other’s strengths and resources for the benefit of all parties involved. In November 2023, for example, Vertex, a call center company based in the UK, formed a partnership with the Switzerland-based biotech firm, CRISPR Therapeutics. Their mutual goal was to develop innovative treatments and they launched the CRISPR/Cas9 Gene-Edited Therapy, CASGEVYTM. The therapy CASGEVY (exagamglogene autotemcel) uses CRISPR/Cas9 technology to modify genes in hematopoietic stem cells which enables the production of functional hemoglobin. This can drastically reduce or even eliminate the painful vaso-occlusive crises associated with sickle cell disease, and lower the need for blood transfusions in patients with transfusion-dependent beta-thalassemia.
Who Are The Leading Companies Driving The CRISPR Technology Market?
Major companies operating in the CRISPR technology market include Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated Dna Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., CSL Limited, C4U Co. Ltd., BGI Group, Churchi Genome Engineering and Therapeutic Research Center., Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, Rosneft, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd, Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Horizon Discovery Group, Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report
Which Region Dominates The CRISPR Technology Market Today?
North America was the largest region in the CRISPR technology market in 2024. Western Europe was the second largest region in the global CRISPR technology market. The regions covered in the CRISPR technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=4018&type=smp
Browse Through More Reports Similar to the Global CRISPR Technology Market 2025, By The Business Research Company
Dna Based Skin Care Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report
Bacterial And Plasmid Vector Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report
Genetic Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model